Serum interleukin-33 levels in patients with gastric cancer. - Wikidata - awgldk - TriplyDB

Serum interleukin-33 levels in patients with gastric cancer.

Serum interleukin-33 levels in patients with gastric cancer.

http://www.wikidata.org/entity/Q39530127

about

Serum IL-33 level is a predictor of progression-free survival after chemotherapy.Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells.Geometrical Frustration in Interleukin-33 Decouples the Dynamics of the Functional Element from the Folding Transition State Ensemble Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice.Association Between Helicobacter pylori cagA, babA2 Virulence Factors and Gastric Mucosal Interleukin-33 mRNA Expression and Clinical Outcomes in Dyspeptic Patients.Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer.Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma.Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection.IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology.Involvement of eosinophils in the anti-tumor response.The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway.Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma.The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.Interleukin-33 in human gliomas: Expression and prognostic significance.IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment.Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.In vitro culture and phenotypic and molecular characterization of gastric stem cells from human stomach.Interleukin-33 Expression does not Correlate with Survival of Gastric Cancer Patients.Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE

P2860

Q33798754-779FDD27-7115-4515-9D41-752FC4A5DF6F Q34405150-5C00CB86-375B-4710-96A0-4A7B93D30E6C Q35858724-46B71DA0-CCFE-42DE-B815-46DA42E33630 Q36444778-6EC159B8-76C0-4469-9904-D5A441CF4676 Q36473012-7444C822-34B8-407F-9947-A67C10E5990D Q36597506-D23FD5C4-7E84-4A1C-8ADC-2B39DD6FF4DF Q36597522-00783791-5BD2-42B3-B3C4-AFBD18A63B8E Q36625735-8316C598-5A2B-4C7B-9C75-45B567C20488 Q36751804-A67A16F0-C4E1-4FCD-961D-68045F822B71 Q36994761-EF59B99D-C0A7-4704-8743-7A1D96B326A4 Q37000128-023B9C9F-5BE5-4C60-9763-F3A5DF05F267 Q37001426-C39E84B8-FEC2-4A8A-9317-084144B52779 Q37109698-2FFF5504-CA40-44D2-AE84-18AD64503F0D Q37174541-27BCF44B-0694-4E2F-82A0-1E9654B44239 Q37439634-CFE3B112-2D8B-42B6-9880-A3289F06B4AB Q37571181-B0831D3F-6671-4402-A712-F2C1DA3303FD Q37634925-6FB50724-D5A5-41DB-899C-9B0FC92E73F3 Q38005217-BD41D4AE-D722-4359-A27C-D78298DB048F Q38019367-9D8FF524-5C6F-495C-85B7-974822308BBA Q38224933-5AF77511-A158-48FB-8E22-13D8415E9640 Q38775054-170D3AE1-1202-4221-B417-ADC94DF1A36B Q38778534-BAA4E065-7343-45B9-BB60-81A2A9D30883 Q38912671-91939B5C-E04F-4AED-873D-187954D5CD4D Q39084378-9675BAD9-599D-4C6F-ACDB-0C700F2D9ADE Q39102545-EAF795DD-C104-47F6-9F58-7631D9EBB5E6 Q39138326-0D154A3F-B8A9-4F42-8E21-C7EE433757BD Q39653025-03231AC4-9862-47D4-AE1A-28EFDD1600DF Q40146282-780DAB91-6EEC-4F56-8CC5-036BF2E9E234 Q40470696-55A898D8-C5E3-4E24-9E16-A6AEEC84FCCC Q40917751-4D635EB5-1F86-4166-AC00-FB060883F0BC Q41573313-461B0C29-4716-4F97-883E-6C5515E510EE Q48120429-DAF66F9C-CD46-4708-B6B1-C76B2930E3B9 Q48371429-FA2C6469-5842-4878-9560-8A2AD9C83EFC Q51070624-099D4F93-7B66-4687-A659-6E8131C5A2D1 Q52141871-2E6B1092-9E12-4A52-BB57-C465FA7787F0 Q58707724-D9DF17FA-D4A9-4C06-8C79-E5396B584DDF Q58770481-F423039F-63B3-4981-B917-6EB99D2D6DC8

P2860

Serum interleukin-33 levels in patients with gastric cancer.

http://www.wikidata.org/entity/Q39530127

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Serum interleukin-33 levels in patients with gastric cancer.

@en

Serum interleukin-33 levels in patients with gastric cancer.

@nl

type

label

Serum interleukin-33 levels in patients with gastric cancer.

@en

Serum interleukin-33 levels in patients with gastric cancer.

@nl

prefLabel

Serum interleukin-33 levels in patients with gastric cancer.

@en

Serum interleukin-33 levels in patients with gastric cancer.

@nl

P1433

Q39530127-2429D42B-740E-4910-ACAD-93EDB194777D

P1476

Q39530127-0CF252C6-2A3B-4CB1-82BA-AAB11E055DE4

P2093

Q39530127-1CB6C220-4EC9-4625-84DB-4024710DEBC6

Q39530127-3DCF6A6A-A8F4-4C3F-9FB5-380FCF263CFD

Q39530127-5500DDCE-289D-405C-A1E5-DAF28D63390B

Q39530127-A025D5E0-B6EE-4157-8E9B-5A268C2A2566

Q39530127-D52F9CB7-8222-49AF-AC8C-6B8DF684FE59

Q39530127-D9EEB536-FE45-4A8A-B622-DDEF735AD53B

P2860

Q39530127-07F359EB-8B03-4E4D-AFF0-839DE8A613A0

Q39530127-1180D0B0-94E7-4737-9A34-DDA22FC137F0

Q39530127-1FAD446D-7565-4448-8721-1C86623E5321

Q39530127-21CFA9A2-E6E5-4209-A852-4523B46C6542

Q39530127-24E711DC-2A96-4D08-90C7-0D95EAFD557C

Q39530127-3C9D2700-3611-4763-A458-5221E5772237

Q39530127-478EACA8-5CC5-406D-AB4C-FD66419A68F2

Q39530127-4930D3C5-9D4A-4EF7-B9B9-52F36FA9DDB3

Q39530127-57942EE2-4EC0-446F-BEDC-AF95AB8DD637

Q39530127-584AF60A-BC1E-443D-9F43-84E8A65A7B2D

P2888

Q39530127-B2F77680-44AE-47C5-8108-B53E56914420

P304

Q39530127-017333DC-0FC7-4FB1-8CB0-6764D1BA259A

P31

Q39530127-EE603333-360F-45EF-8291-7836EF4C83CF

P356

Q39530127-C6E60202-EC14-4510-8EE5-93B17A5CB8FC

P433

Q39530127-EABC7568-D819-42C6-9952-300080B9A1D0

P478

Q39530127-4FF72098-1328-4020-8092-111D5354A068

P577

Q39530127-4466019B-1A88-49D7-B015-7D4E31AE4F1F

P698

Q39530127-9D309248-B912-4925-AF70-3254B1DC7B63

P921

Q39530127-27fd64c6-dcd5-4499-be25-4353381999cd

P356

S10620-011-1760-5

P1433

Digestive Diseases and Sciences

P1476

Serum interleukin-33 levels in patients with gastric cancer.

@en

P2093

Pinghu Sun

http://www.w3.org/2001/XMLSchema#string

Qiwen Ben

http://www.w3.org/2001/XMLSchema#string

Shuiping Tu

http://www.w3.org/2001/XMLSchema#string

Wenjie Dong

http://www.w3.org/2001/XMLSchema#string

Xiaoguang Qi

http://www.w3.org/2001/XMLSchema#string

Yunlin Wu

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Cloning of a putative ligand for the T1/ST2 receptor

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage.

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

Diagnostic role of serum interleukin-18 in gastric cancer patients.

The epidemiology of gastric cancer.

The IL-33/ST2 pathway: therapeutic target and novel biomarker.

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.

P2888

s10620-011-1760-5

P304

3596-3601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-011-1760-5

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21643739

http://www.w3.org/2001/XMLSchema#string

P921